Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
kate.thomson@cardiov.ox.ac.uk

Research groups

Ferreira Group: Quantitative cardiac magnetic resonance myocardial tissue characterisation

Kate Thomson

Clinical Research Fellow

Recent publications

Hypertrophic cardiomyopathy caused by Filamin-C (FLNC) variants has restrictive and extracardiac features and a distinctive ECG.

de Villiers C. et al, (2026), Heart Rhythm

Titin-related familial dilated cardiomyopathy: factors associated with disease onset.

Johnson R. et al, (2025), Eur Heart J, 46, 5240 - 5257

are splice-site variant in TNNT2: the need for ancestral diversity in genomic reference data sets.

Butters A. et al, (2025), Eur Heart J, 46, 1446 - 1449

Combined RNA Splicing and Patch-Clamp Analysis Reveal Pathogenicity of Splice-Altering Variants in KCNH2-Related LQTS.

Clasper S. et al, (2025), Circ Genom Precis Med, 18

An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten.

Leinhos L. et al, (2025), Sci Rep, 15

More publications